Zumtobel Group AG
VSE:ZAG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zumtobel Group AG
VSE:ZAG
|
AT |
|
PCB Bancorp
NASDAQ:PCB
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
Prosus NV
AEX:PRX
|
NL |
|
Galapagos NV
AEX:GLPG
|
BE |
|
Cidara Therapeutics Inc
NASDAQ:CDTX
|
US |
|
Caixabank SA
F:48CA
|
ES |
|
Varonis Systems Inc
NASDAQ:VRNS
|
US |
|
Safety Shot Inc
NASDAQ:SHOT
|
US |
|
Becle SAB de CV
BMV:CUERVO
|
MX |
|
Blue Bird Corp
NASDAQ:BLBD
|
US |
|
GMexico Transportes SAB de CV
BMV:GMXT
|
MX |
Wall St Price Targets
ZAG Price Targets Summary
Zumtobel Group AG
According to Wall Street analysts, the average 1-year price target for ZAG is 4.83 EUR with a low forecast of 4.34 EUR and a high forecast of 5.67 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZAG's stock price target?
Price Target
4.83
EUR
According to Wall Street analysts, the average 1-year price target for ZAG is 4.83 EUR with a low forecast of 4.34 EUR and a high forecast of 5.67 EUR.
What is the Revenue forecast for Zumtobel Group AG?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for Zumtobel Group AG?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Zumtobel Group AG?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 31%.
